166 related articles for article (PubMed ID: 26266390)
1. Increasing Receipt of High-Tech/High-Cost Imaging and Its Determinants in the Last Month of Taiwanese Patients With Metastatic Cancer, 2001-2010: A Retrospective Cohort Study.
Liu TW; Hung YN; Soong TC; Tang ST
Medicine (Baltimore); 2015 Aug; 94(32):e1354. PubMed ID: 26266390
[TBL] [Abstract][Full Text] [Related]
2. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
3. Trend in and Correlates of Undergoing Radiotherapy in Taiwanese Cancer Patients' Last Month of Life.
Hung YN; Cheng SH; Liu TW; Chang WC; Chen JS; Tang ST
J Pain Symptom Manage; 2016 Sep; 52(3):395-403. PubMed ID: 27265817
[TBL] [Abstract][Full Text] [Related]
4. Receipt of Life-Sustaining Treatments for Taiwanese Pediatric Patients Who Died of Cancer in 2001 to 2010: A Retrospective Cohort Study.
Hung YN; Liu TW; Lin DT; Chen YC; Chen JS; Tang ST
Medicine (Baltimore); 2016 Apr; 95(16):e3461. PubMed ID: 27100448
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Correlates of Increasing Use of Surgery in Taiwanese Cancer Patients' Last Month of Life, 2001-2010.
Liu TW; Hung YN; Earle CC; Liu TP; Liu LN; Tang ST
Ann Surg; 2016 Aug; 264(2):283-90. PubMed ID: 26655921
[TBL] [Abstract][Full Text] [Related]
6. Latent class analysis identifies three subtypes of aggressive end-of-life care: a population-based study in Taiwan.
Chen ML; Chen YY; Tang ST
Eur J Cancer; 2013 Oct; 49(15):3284-91. PubMed ID: 23756054
[TBL] [Abstract][Full Text] [Related]
7. Preferences for Aggressive End-of-life Care and Their Determinants Among Taiwanese Terminally Ill Cancer Patients.
Liu LN; Chen CH; Liu TW; Lin YC; Lee SC; Tang ST
Cancer Nurs; 2015; 38(3):E9-E18. PubMed ID: 24915466
[TBL] [Abstract][Full Text] [Related]
8. Impact of Targeted Therapy on the Quality of End-of-Life Care for Patients With Non-Small-Cell Lung Cancer: A Population-Based Study in Taiwan.
Tsai HY; Chung KP; Kuo RN
J Pain Symptom Manage; 2018 Mar; 55(3):798-807.e4. PubMed ID: 29056563
[TBL] [Abstract][Full Text] [Related]
9. Determinants of aggressive end-of-life care for Taiwanese cancer decedents, 2001 to 2006.
Tang ST; Wu SC; Hung YN; Chen JS; Huang EW; Liu TW
J Clin Oncol; 2009 Sep; 27(27):4613-8. PubMed ID: 19704067
[TBL] [Abstract][Full Text] [Related]
10. Quality of end-of-life care between medical oncologists and other physician specialists for Taiwanese cancer decedents, 2001-2006.
Liu TW; Chen JS; Wang HM; Wu SC; Hung YN; Tang ST
Oncologist; 2009 Dec; 14(12):1232-41. PubMed ID: 20007642
[TBL] [Abstract][Full Text] [Related]
11. Low socioeconomic status is associated with more aggressive end-of-life care for working-age terminal cancer patients.
Chang CM; Wu CC; Yin WY; Juang SY; Yu CH; Lee CC
Oncologist; 2014 Dec; 19(12):1241-8. PubMed ID: 25342317
[TBL] [Abstract][Full Text] [Related]
12. A population-based study on the determinants of hospice utilization in the last year of life for Taiwanese cancer decedents, 2001-2006.
Tang ST; Huang EW; Liu TW; Wang HM; Chen JS
Psychooncology; 2010 Nov; 19(11):1213-20. PubMed ID: 20119936
[TBL] [Abstract][Full Text] [Related]
13. Determinants for aggressive end-of-life care for oral cancer patients: a population-based study in an Asian country.
Chang TS; Su YC; Lee CC
Medicine (Baltimore); 2015 Jan; 94(4):e460. PubMed ID: 25634186
[TBL] [Abstract][Full Text] [Related]
14. The economic burden of end-of-life care in metastatic breast cancer.
Bramley T; Antao V; Lunacsek O; Hennenfent K; Masaquel A
J Med Econ; 2016 Nov; 19(11):1075-1080. PubMed ID: 27248201
[TBL] [Abstract][Full Text] [Related]
15. Impact of age on end-of-life care for adult Taiwanese cancer decedents, 2001-2006.
Tang ST; Liu TW; Shyu YI; Huang EW; Koong SL; Hsiao SC
Palliat Med; 2012 Jan; 26(1):80-8. PubMed ID: 21606128
[TBL] [Abstract][Full Text] [Related]
16. Association of Early Patient-Physician Care Planning Discussions and End-of-Life Care Intensity in Advanced Cancer.
Ahluwalia SC; Tisnado DM; Walling AM; Dy SM; Asch SM; Ettner SL; Kim B; Pantoja P; Schreibeis-Baum HC; Lorenz KA
J Palliat Med; 2015 Oct; 18(10):834-41. PubMed ID: 26186553
[TBL] [Abstract][Full Text] [Related]
17. Use of chemotherapy at the end of life among Taiwanese cancer decedents, 2001-2006.
Liu TW; Chang WC; Wang HM; Chen JS; Koong SL; Hsiao SC; Tang ST
Acta Oncol; 2012 Apr; 51(4):505-11. PubMed ID: 22283469
[TBL] [Abstract][Full Text] [Related]
18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
19. Association of healthcare expenditures with aggressive versus palliative care for cancer patients at the end of life: a cross-sectional study using claims data in Japan.
Morishima T; Lee J; Otsubo T; Imanaka Y
Int J Qual Health Care; 2014 Feb; 26(1):79-86. PubMed ID: 24225269
[TBL] [Abstract][Full Text] [Related]
20. Medical care costs at the end of life among older adults with cancer: a national health insurance data-based cohort study.
Jo M; Lee Y; Kim T
BMC Palliat Care; 2023 Jun; 22(1):76. PubMed ID: 37349710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
